Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
BackgroundTranscriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284 · cited 1×
“It has been reported that Langerhans cells in the skin and microglial cells in the brain, which are tissue-resident macrophage populations that are radiation resistant, seem to be maintained through local proliferation, and recent studies indicate that these cells initially develop from M-CFU in the yolk sac of the de…”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225 · cited 1×
“It has been demonstrated that TAM infiltration is positively correlated with the proliferation of tumor cells in several tumors, such as breast cancer, endometrial cancer, and renal cell cancer [59, 60].”
BackgroundHIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769 · cited 1×
“In the 1970s, it was found that TAMs, as the predominant leukocyte, play a key role in tumor growth [26].”
BackgroundThe Cell Biology of Macrophage Activation
Adams, D. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.283 · Cited by 1,604 · cited 1×
“Both of the signals can activate MTC and resist tumor activity [108].”
BackgroundColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594 · cited 1×
“RNA (siRNA) in mice model, macrophage infiltration and vascularity are decreased compared to their CSF-1 counterparts [47, 48].”
BackgroundMacrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484 · cited 1×
“In the innate immune response, TGF-β promotes tumor-associated macrophage polarization to an M2-versus-M1 phenotype, which further promotes TGF-β production and deepens immunosuppression [78].”
BackgroundTumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425 · cited 12×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialTGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355 · cited 1×
“TGF-β also inhibits the CD8+ T cells antitumor activity by suppressing the expression of several cytolytic genes, including the genes encoding granzyme A, granzyme B, IFN-γ, and FAS ligand [79, 84].”
BackgroundMacrophage Polarization in Bacterial Infections
Benoit, M., Desnues, B., & Mege, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3733 · Cited by 1,329 · cited 2×
“For example, the IL-12 produced by M1 macrophages can promote the differentiation of Th1 cells, which can improve antigen phagocytosis [12, 16].”
BackgroundTumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905680 · Cited by 1,262 · cited 1×
“Accumulating studies have demonstrated that the density of TAMs is associated with a poor prognosis, suggesting macrophages as a target for clinical therapy [104–107].”
BackgroundMacrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259 · cited 1×
“When stimulated with IFN-γ, M1 macrophages secrete high levels of IL-12 and IL-23 but low levels of IL-10 [3, 12–14].”
BackgroundTherapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246 · cited 1×
“Several articles have reported that activation of TLRs stimulates M1-polarized macrophage response, which induce the activation of proinflammatory program [116].”
BackgroundMacrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241 · cited 1×
“For example, during tumor progression, the macrophage phenotype changes from classically activated to alternatively activated [23].”
BackgroundWyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188 · cited 2×
“Subsequently, Wyckoff and colleagues demonstrated a synergistic relationship between breast cancer cells and TAMs in cell migration [67].”
BackgroundSindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100 · cited 2×
“, TNF-α, IL-1, IL-6, IL-12, and IL-23) and increase their concentrations of superoxide anions, oxygen radicals, and nitrogen radicals [8, 9].”
BackgroundMacrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074 · cited 1×
“RNA (siRNA) in mice model, macrophage infiltration and vascularity are decreased compared to their CSF-1 counterparts [47, 48].”
BackgroundDirect Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053 · cited 1×
“Accumulating studies have verified that the malignant cells always move next to the TAMs, which appear to help malignant cells during intravasation [69].”
BackgroundThe inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044 · cited 1×
“Other chemokines, such as CCL3, CCL4, CCL5, CCL7, CCL8, CXCL12, and cytokines, including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and IL-10, are also reported to promote macrophage recruitment [14, 37–39].”
BackgroundVerreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., & Ottenhoff, T. H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400983101 · Cited by 977 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundThe polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940 · cited 3×
“TGF-β also inhibits the CD8+ T cells antitumor activity by suppressing the expression of several cytolytic genes, including the genes encoding granzyme A, granzyme B, IFN-γ, and FAS ligand [79, 84].”
BackgroundMurdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915 · cited 1×
“Other chemokines, such as CCL3, CCL4, CCL5, CCL7, CCL8, CXCL12, and cytokines, including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and IL-10, are also reported to promote macrophage recruitment [14, 37–39].”
BackgroundKuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903 · cited 1×
“Recently, it was reported that an anti-PD-L1 antibody, which blocks the PD-1/PD-L1 pathway, can improve macrophagemediated T-cell activation in HCC in vivo and has progressed to a phase I clinical study [121, 122].”
BackgroundKusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850 · cited 2×
“In addition, several studies have reported that arginase 1 activation is associated with H2O2 production by myeloid-derived suppressor cells (MDSCs), which present class I-restricted epitopes directly to CD8+ T cells and inhibit their release of IFN-γ through the contact-dependent production of H2O2 [93].”
BackgroundRegulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841 · cited 1×
“In addition, it has been reported that the HIF-1-dependent chemokine CXCL-12 acts as a potent chemoattractant that promotes endothelial cell infiltration when specifically combined with its sole receptor, CXCR4 [52].”
BackgroundGao, Q., Wang, X.-Y., Qiu, S.-J., Yamato, I., Sho, M., Nakajima, Y., Zhou, J., Li, B.-Z., Shi, Y.-H., Xiao, Y.-S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1608 · Cited by 813 · cited 1×
“Recently, it was reported that an anti-PD-L1 antibody, which blocks the PD-1/PD-L1 pathway, can improve macrophagemediated T-cell activation in HCC in vivo and has progressed to a phase I clinical study [121, 122].”
BackgroundSchoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., & Kerjaschki, D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64255-1 · Cited by 794 · cited 2×
“In human cervical cancer, the VEGF-C released by TAMs plays a novel role in peritumoral lymphangiogenesis and the subsequent formation of lymphatic metastases [54].”
BackgroundCastriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages
Maruyama, K., Ii, M., Cursiefen, C., Jackson, D. G., Keino, H., Tomita, M., Van Rooijen, N., Takenaka, H., D’Amore, P. A., Stein-Streilein, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23874 · Cited by 712
Giraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700 · cited 1×
“MMP-9 is one of the most important proteases that degrade the extracellular matrix (ECM) and further release other growth factors to stimulate angiogenesis [49, 50].”
BackgroundThe Increasing Complexity of the Cancer Stem Cell Paradigm
Rosen, J. M., & Jordan, C. T. (2009) · Science · doi:10.1126/science.1171837 · Cited by 698 · cited 1×
“However, stromal cells, such as fibroblasts and immune cells, are also known to play important roles in tumor progression [97].”
BackgroundBiswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696 · cited 1×
“In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth.”
BackgroundYang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.-D., & Song, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-117 · Cited by 693 · cited 1×
“miR-233-regulating tumor invasion is considered to work through the mef2c-βcatinen pathway [74].”
BackgroundGlioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691 · cited 1×
“In addition, M2 macrophages could induce T-cell anergy and therefore immunosuppression in agreement with what we mentioned previously [101].”
ResultThe Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
BackgroundZeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623 · cited 1×
“found that depleting TAMs with clodronate encapsulated in liposomes (clodrolip) could reduce blood vessel density in the tumor tissue [44].”
BackgroundTumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., & Bronte, V. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00602.x · Cited by 608 · cited 2×
“In recent years, it has been demonstrated that arginase 1, which primarily metabolizes L-arginine into polyamine and proline, causes dysregulation of the T cell receptor (TCR) signal and subsequently induces CD8+ T cell unresponsiveness [77, 92].”
BackgroundStem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Zeppernick, F., Ahmadi, R., Campos, B., Dictus, C., Helmke, B. M., Becker, N., Lichter, P., Unterberg, A., Radlwimmer, B., & Herold-Mende, C. C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0932 · Cited by 588 · cited 1×
“Several studies have reported that TAMs are always found distributed around CSCs, and the number of infiltrating TAMs has been positively correlated with the histological grade of the malignancy and the number of CSCs found [98, 99].”
BackgroundObstacles and opportunities for understanding macrophage polarization
Murray, P. J., & Wynn, T. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710409 · Cited by 563 · cited 1×
“By analogy to the Th1/ Th2 classification, two distinct states of polarized activation for macrophages have been proposed: the classically activated (M1) macrophage and the alternatively activated (M2) macrophage subsets [5].”
BackgroundModolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250436 · Cited by 554 · cited 1×
“M1 macrophages can also secrete high levels of inducible nitric oxide synthase (iNOS; NOS2) to promote arginine metabolized into nitric oxide and citrulline [11].”
BackgroundGuiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549 · cited 1×
“found that CpG plus antiinterleukin-10 receptor antibody promptly switched infiltrating macrophages infiltrate from M2 to M1 and triggered innate response debulking large tumors [117].”
BackgroundJinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479 · cited 1×
“MFG-E8 induces CSCs to form tumors and develop antitumor drug resistance through the STAT3 and hedgehog signaling pathways [102].”
BackgroundAdipose tissue macrophages: their role in adipose tissue remodeling
Suganami, T., & Ogawa, Y. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0210072 · Cited by 445 · cited 1×
“In contrast, the macrophage phenotype changes from M2 to M1 in obesity [24].”
BackgroundNuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Luo, J.-L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., & Karin, M. (2007) · Nature · doi:10.1038/nature05656 · Cited by 436
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 426 · cited 1×
“IL-10 can also inhibit the release of the cytotoxic cytokine IFN-γ, which is the main factor that stimulates naı̈ve T-cell differentiation, to promote immune evasion [87].”
BackgroundInterleukin-10 and the immune response against cancer: a counterpoint
Mocellin, S., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 402 · cited 1×
“Some articles reported that IL-10 possesses some immunostimulating properties, which play important roles in antitumor response [89–91].”
BackgroundMMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., Vargo-Gogola, T. C., Begtrup, J. L., Peterson, T. E., Fingleton, B., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.013 · Cited by 393 · cited 2×
“showed that MMP7 could also promote tumor metastasis through converting the receptor activator of nuclear factor κB ligand (RANKL) [72, 73].”
BackgroundHagemann, T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh146 · Cited by 375 · cited 1×
“Hagemann and colleagues demonstrated that coculturing TAMs with tumor cells can promote the expression of MMPs, especially MMP2 and MMP9, in TNF-α-dependent manner [71].”
BackgroundZhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 366 · cited 1×
“It has been demonstrated that TAM infiltration is positively correlated with the proliferation of tumor cells in several tumors, such as breast cancer, endometrial cancer, and renal cell cancer [59, 60].”
BackgroundTumor-associated macrophages: Effectors of angiogenesis and tumor progression
Coffelt, S. B., Hughes, R., & Lewis, C. E. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.02.004 · Cited by 355 · cited 5×
“Other alarmins, such as S100A8, S100A9, serum amyloid A3 (SAA3), and fibronectin, have also been reported to attract CD11b+ myeloid cells [41].”
BackgroundInfluentialCancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
Pallini, R., Ricci-Vitiani, L., Banna, G. L., Signore, M., Lombardi, D., Todaro, M., Stassi, G., Martini, M., Maira, G., Larocca, L. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0644 · Cited by 355 · cited 1×
“Several studies have reported that TAMs are always found distributed around CSCs, and the number of infiltrating TAMs has been positively correlated with the histological grade of the malignancy and the number of CSCs found [98, 99].”
BackgroundRole of macrophages in tumour progression
Siveen, K. S., & Kuttan, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.02.011 · Cited by 353 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMantovani, A., Sica, A., Allavena, P., Garlanda, C., & Locati, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.02.008 · Cited by 350 · cited 1×
“In addition, the IL-10 expressed by M2 macrophages can promote the production of IL-4 and IL-13 by Th2 cells [19].”
BackgroundHuang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349 · cited 1×
“The cytokine IL-23 is considered to promote tumor incidence and growth by upregulating MMP9, thereby stimulating inflammatory responses [62, 63].”
BackgroundBENBARUCH, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 335 · cited 2×
“CCL-2 and CCL5, which were mentioned previously as chemoattractants of monocytes to tumors, induce suppression of T-cell responses [76].”
BackgroundFusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis
Pawelek, J. M., & Chakraborty, A. K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2371 · Cited by 325 · cited 1×
“Pawelek and Chakraborty even proposed that when cancer cells fuse with migratory bone marrow-derived cells, they provide the driving force behind the dissemination process [70].”
BackgroundTumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Erreni, M., Mantovani, A., & Allavena, P. (2011) · Cancer Microenvironment · doi:10.1007/s12307-010-0052-5 · Cited by 325 · cited 1×
“The cytokine IL-23 is considered to promote tumor incidence and growth by upregulating MMP9, thereby stimulating inflammatory responses [62, 63].”
BackgroundMatsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Alternatively activated macrophages in infection and autoimmunity
Fairweather, D., & Cihakova, D. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.012 · Cited by 290 · cited 1×
“, TNF-α, IL-1, IL-6, IL-12, and IL-23) and increase their concentrations of superoxide anions, oxygen radicals, and nitrogen radicals [8, 9].”
BackgroundMaeda, H., & Shiraishi, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.73 · Cited by 272
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 259
Mechanisms of macrophage activation in obesity-induced insulin resistance
Odegaard, J. I., & Chawla, A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0976 · Cited by 256 · cited 1×
“citrulline, but M2 macrophages induce arginase 1, which metabolizes arginine to ornithine and polyamines, which are precursors necessary for collagen synthesis and cellular proliferation [20].”
BackgroundChen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., & Luo, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1354 · Cited by 227
The crucial role of macrophages in lymphangiogenesis
Kerjaschki, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26354 · Cited by 225 · cited 1×
“These findings suggest that macrophages induce lymphangiogenesis in two different ways, either by transdifferentiating and directly incorporating into the endothelial layer or by stimulating the division of preexisting local lymphatic endothelial cells [58].”
BackgroundThe Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
Beck, A. H., Espinosa, I., Edris, B., Li, R., Montgomery, K., Zhu, S., Varma, S., Marinelli, R. J., van de Rijn, M., & West, R. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1283 · Cited by 210 · cited 1×
“In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth.”
BackgroundIdentification of Monocyte Chemotactic Activity Produced by Malignant Cells
Graves, D. T., Jiang, Y. L., Williamson, M. J., & Valente, A. J. (1989) · Science · doi:10.1126/science.2781291 · Cited by 206 · cited 1×
“For instance, tumorderived chemokine CCL2, formerly known as monocyte chemotactic protein (MCP), is critical for the recruitment of macrophages [34, 35].”
BackgroundDineen, S. P., Lynn, K. D., Holloway, S. E., Miller, A. F., Sullivan, J. P., Shames, D. S., Beck, A. W., Barnett, C. C., Fleming, J. B., & Brekken, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6705 · Cited by 203 · cited 1×
“Several studies revealed that anti-VEGF-A with Avastin/bevacizumab or other neutralizing antibodies can both inhibit the infiltration of macrophages and enhance the activity of antiangiogenic therapies by preventing TAMs from secreting additional proangiogenic factors [114, 115].”
BackgroundOkuda, H., Kobayashi, A., Xia, B., Watabe, M., Pai, S. K., Hirota, S., Xing, F., Liu, W., Pandey, P. R., Fukuda, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1678 · Cited by 201 · cited 1×
“The interaction between CSCs and TAMs through hyaluronan stimulates the secretion of PDGF-BB, which in turn activates stromal cells to secrete the FGF7 and FGF9 that stimulate CSC proliferation, selfrenewal and metastasis in the bone [103].”
BackgroundQin, Z., Noffz, G., Mohaupt, M., & Blankenstein, T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.770 · Cited by 193 · cited 1×
“Several studies have reported that TAM-derived IL-10 prevents the maturation of DCs in situ but increases the differentiation of macrophages, which decreases antigen presentation [76, 86].”
BackgroundIL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., & Granstein, R. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1280 · Cited by 184 · cited 1×
“Furthermore, it has been reported that IL-10 decreases the ability of epidermal APCs to present tumor-associated antigens for the induction of antitumor immune responses in a spindle cell tumor system [88].”
BackgroundSalvesen, H. B., & Akslen, L. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<538::aid-ijc17>3.0.co;2-b · Cited by 182
Inhibition of IFN-γ Signaling by Glucocorticoids
Hu, X., Li, W.-P., Meng, C., & Ivashkiv, L. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4833 · Cited by 177
Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma
Liang, Y., Xiao, H., Xu, M., Ye, X.-Z., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.011 · Cited by 172 · cited 2×
“Furthermore, Yi, et al. found that the production of CSCderived chemoattractants, including CCL2, CCL5, VEGF-A, and NTS, in glioma tissue was much higher than in adhesive glioma cells (AGCs), which promotes the infiltration of macrophages.”
Ji, R.-C. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9026-y · Cited by 168 · cited 1×
“In addition, TAMs can express lymphatic endothelial growth factors to promote lymphangiogenesis [54, 56].”
BackgroundCancer initiation and progression: Involvement of stem cells and the microenvironment
Tysnes, B. B., & BJERKVIG, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.01.001 · Cited by 164 · cited 1×
“A CSC has the ability to initiate tumorigenesis by undergoing self-renewal and differentiation [95, 96].”
BackgroundTrabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails
Sessa, C., De Braud, F., Perotti, A., Bauer, J., Curigliano, G., Noberasco, C., Zanaboni, F., Gianni, L., Marsoni, S., Jimeno, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.032 · Cited by 162 · cited 1×
“In addition, some studies have shown that Trabectedin, a natural product derived from the marine organism Ecteinascidia turbinata, has a specific cytotoxic effect on human macrophages and TAMs in vitro [110].”
BackgroundMacrophage polarization and HIV-1 infection
Cassol, E., Cassetta, L., Alfano, M., & Poli, G. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1009673 · Cited by 161 · cited 1×
“For example, the IL-12 produced by M1 macrophages can promote the differentiation of Th1 cells, which can improve antigen phagocytosis [12, 16].”
BackgroundTumor-Derived TGFβ-1 Induces Dendritic Cell Apoptosis in the Sentinel Lymph Node
Ito, M., Minamiya, Y., Kawai, H., Saitô, S., Saito, H., Nakagawa, T., Imai, K., Hirokawa, M., & Ogawa, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5637 · Cited by 160 · cited 1×
“In addition, TGF-β decreases dendritic cells (DCs) migration and increases apoptosis, which decreases antigen presentation and dampens the adaptive immune response [81, 82].”
BackgroundFujimoto, J., Sakaguchi, H., Aoki, I., & Tamaya, T. (2000) · PubMed · Cited by 154
Mukhtar, R. A., Nseyo, O., Campbell, M. J., & Esserman, L. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.97 · Cited by 154 · cited 1×
“” Tumors are composed of proliferating tumor cells and stromal cells, including endothelial cells, inflammatory cells, and fibroblasts [25].”
BackgroundOng, S., Tan, Y., Beretta, O., Jiang, D., Yeap, W., Tai, J. J. Y., Wong, W., Yang, H., Schwarz, H., Lim, K., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201141825 · Cited by 145 · cited 2×
“It has been reported that in colorectal tumors TAMs are proinflammatory, and play an antitumor role, which leads to a good prognosis [27, 28].”
BackgroundTumor-associated macrophages: a molecular perspective
Sica, A., Saccani, A., & Mantovani, A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00064-4 · Cited by 123 · cited 1×
“On the other hand, the tumor microenvironment includes a number of chemoattractants, such as IL-4, IL-13, TGF-β, and IL-10, all of which lead to the adoption of an M2 phenotype [33].”
BackgroundMacrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents
Joseph, I. B. J., & Isaacs, J. T. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1648 · Cited by 116 · cited 1×
“Other pharmacological drugs, including thalidomide, linomide, pentoxifyline, and genistein, have also been shown to inhibit macrophage infiltration and reduce tumor size [112, 113].”
BackgroundVukanovic, J., & Isaacs, J. T. (1995) · PubMed · Cited by 102
Whitehurst, B. D., Flister, M. J., Bagaitkar, J., Volk, L. D., Bivens, C., Pickett, B., Castro‐Rivera, E., Brekken, R. A., Gerard, R. D., & Ran, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22937 · Cited by 97 · cited 1×
“Several studies revealed that anti-VEGF-A with Avastin/bevacizumab or other neutralizing antibodies can both inhibit the infiltration of macrophages and enhance the activity of antiangiogenic therapies by preventing TAMs from secreting additional proangiogenic factors [114, 115].”
BackgroundMurine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression
Bąk, S., Alonso, A., Turk, M. J., & Berwin, B. L. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.266 · Cited by 96 · cited 1×
“In recent years, it has been demonstrated that arginase 1, which primarily metabolizes L-arginine into polyamine and proline, causes dysregulation of the T cell receptor (TCR) signal and subsequently induces CD8+ T cell unresponsiveness [77, 92].”
BackgroundKaafarani, I., Fernandez-Sauze, S., Berenguer‐Daizé, C., Chinot, O. L., Delfino, C., Dussert, C., Métellus, P., Boudouresque, F., Mabrouk, K., Grisoli, F., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-127852 · Cited by 93
Extracellular proteolysis in macrophage migration: Losing grip for a breakthrough
Vérollet, C., Charrière, G. M., Labrousse, A., Cougoule, C., Le Cabec, V., & Maridonneau‐Parini, I. (2011) · European Journal of Immunology · doi:10.1002/eji.201141538 · Cited by 91 · cited 1×
“MMP-9 is one of the most important proteases that degrade the extracellular matrix (ECM) and further release other growth factors to stimulate angiogenesis [49, 50].”
BackgroundNardin, A., & Abastado, J.-P. (2008) · Frontiers in bioscience · doi:10.2741/2944 · Cited by 89
Coffelt, S. B., & Scandurro, A. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0044 · Cited by 88 · cited 1×
“another group of monocyte chemoattractants, the alarmins, have been reported to promote the recruitment of monocytes and other myeloid cells [40].”
BackgroundTumor Versus Tumor-Associated Macrophages: How Hot is the Link?
Guruvayoorappan, C. (2008) · Integrative Cancer Therapies · doi:10.1177/1534735408319060 · Cited by 87 · cited 6×
“Macrophages cocultured with tumor cells could secrete a series of substances which facilitate tumor cell proliferation [42].”
BackgroundInfluentialKurte, M., López, M. N., Aguirre, A., Escobar, A. F., Aguillón, J. C., Charo, J., Larsen, C. G., Kiessling, R. W., & Salazar‐Onfray, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1731 · Cited by 85
Weber, F., Byrne, S. N., Le, S., Brown, D. A., Breit, S. N., Scolyer, R. A., & Halliday, G. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0652-3 · Cited by 83 · cited 1×
“In addition, TGF-β decreases dendritic cells (DCs) migration and increases apoptosis, which decreases antigen presentation and dampens the adaptive immune response [81, 82].”
BackgroundThe role of SHIP1 in macrophage programming and activation
Rauh, M. J., Sly, L. M., Kalesnikoff, J., Hughes, M. R., Cao, L., Lam, V., & Krystal, G. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320785 · Cited by 75 · cited 1×
“Therefore, pharmacological modulators of this phosphatase that can promote the infiltration of M1 macrophages and inhibit M2 macrophages, thereby enhancing the antitumor effects of M1 cytotoxicity, are under investigation [14, 118].”
BackgroundAugmentation of metastasis formation by thioglycollate‐elicited macrophages
Gorelik, E., Wiltrout, R. H., Brunda, M. J., Holden, H. T., & Herberman, R. B. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290514 · Cited by 72 · cited 1×
“After intravenous injection of murine tumor cells, the macrophage population increased during the formation of lung tumor nodules [68].”
BackgroundSatoh, T., Saika, T., Ebara, S., Kusaka, N., Timme, T. L., Yang, G., Wang, J., MOURAVIEV, V. B., Cao, G., Fattah, E. M. A., et al. (2003) · PubMed · Cited by 70
Nathan, C. (2008) · Nature Immunology · doi:10.1038/ni0708-695 · Cited by 66 · cited 1×
“Macrophages were initially described by Elie Metchnikoff, who won the Nobel prize in 1905 because of his identification of phagocytes and his phagocytosis theory [1].”
BackgroundSakai, Y., Honda, M., Fujinaga, H., Tatsumi, I., Mizukoshi, E., Nakamoto, Y., & Kaneko, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0911 · Cited by 65 · cited 1×
“In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth.”
BackgroundCancer stem cells and angiogenesis
Bjerkvig, R., Johansson, M., Miletić, H., & Niclou, S. P. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.09.001 · Cited by 56
Brekhman, V., Lugassie, J., Zaffryar‐Eilot, S., Sabo, E., Kessler, O., Smith, V., Golding, H., & Neufeld, G. (2010) · The FASEB Journal · doi:10.1096/fj.10-162677 · Cited by 54 · cited 1×
“The inhibition of adrenomedullin receptors on TAMs impairs angiogenesis and tumor growth [65, 66].”
BackgroundExpression of galectin-3 in the tumor immune response in colon cancer
Dumont, P., Berton, A., Nagy, N., Sandras, F., Tinton, S. A., Demetter, P., Mascart, F., Allaoui, A., Decaestecker, C., & Salmon, I. J. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.54 · Cited by 47 · cited 2×
“It has been reported that in colorectal tumors TAMs are proinflammatory, and play an antitumor role, which leads to a good prognosis [27, 28].”
BackgroundCD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer
Miotto, D., Cascio, N. L., Stendardo, M., Querzoli, P., Pedriali, M., Rosa, E. D., Fabbri, L. M., Mapp, C. E., & Boschetto, P. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.12.012 · Cited by 39 · cited 1×
“For example, in NSCLS stage I, it is found that the more infiltrating CD8+/IL-10+ cells there are, the longer the overall survival will be [89].”
BackgroundLopez, M. V., Adris, S., Bravo, A., Chernajovsky, Y., & Podhajcer, O. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5885 · Cited by 37 · cited 1×
“Some articles reported that IL-10 possesses some immunostimulating properties, which play important roles in antitumor response [89–91].”
BackgroundTanaka, Y., Kobayashi, H., Suzuki, M., Kanayama, N., Suzuki, M., & Terao, T. (2002) · Human Pathology · doi:10.1053/hupa.2002.129203 · Cited by 37 · cited 1×
“For instance, TAMs release growth factors such as VEGF, PDGF, transforming growth factor β (TGF-β), and a member of the FGF family, which can promote angiogenesis in many tumors, such as gliomas, squamous cell carcinomas of the esophagus, and breast, bladder, and prostate carcinomas [14, 36, 45].”
BackgroundKr̨ecicki, T., Zalesska−Kręcicka, M., Jeleń, M., Szkudlarek, T., & Horobiowska, M. (2001) · Clinical Otolaryngology · doi:10.1046/j.0307-7772.2001.00503.x · Cited by 33 · cited 1×
“MMP-2 expression is also increased in several tumors, which is correlated with the nodal status and tumor stages [51].”
BackgroundLei, H., Ju, D., Yu, Y., Tao, Q., Chen, G., Gu, S., Hamada, H., & Cao, X. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301162 · Cited by 28 · cited 1×
“In addition, accumulating studies report using macrophages as natural vectors to deliver therapeutic molecules to the neoplastic site [14, 41, 119].”
BackgroundTarget Validation Using RNA Interference in Solid Tumors
Aharinejad, S., Sioud, M., Lucas, T., & Abraham, D. (2006) · Humana Press eBooks · doi:10.1385/1-59745-208-4:227 · Cited by 24 · cited 1×
“found that the overexpression of colonystimulating factor 1 (CSF-1) can enhance the recruitment of TAMs, which accelerates tumor development and malignant progression in the mammary epithelium of MMTV-PyMT mice [46].”
BackgroundEffect of macrophage depletion on growth and neovascularization of hamster buccal pouch carcinomas
Polverini, P. J., & Leibovich, S. J. (1987) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1987.tb00714.x · Cited by 23
Miyata, Y., Ohba, K., Kanda, S., Nomata, K., Eguchi, J., Hayashi, T., & Kanetake, H. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0198-1 · Cited by 16 · cited 1×
“However, in bladder cancer, VEGF-C expression was positively associated with both lymphangiogenesis and angiogenesis, while VEGF-D was associated only with lymphangiogenesis [55].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
“M2 macrophages are generally considered to be the phenotype of tumor-associated macrophages (TAMs), [454] [455] [456] have immunosuppressive and angiogenesis-promoting effects, and are considered to be a tumor-promoting cell type.”
BackgroundTumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
“Other CC chemokines including CCL3, CCL4, CCL5 (RANTES), and CCL22 (macrophage-derived chemokine) and some CXC chemokines, in particular CXCL8, may also be involved in TAM recruitment [6,26,27], because they are highly expressed in many human tumors and various tumor cell lines.”
BackgroundThe Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
“Moreover, TGF-β-secreting cells such as TAMs and tumor cells suppress T cells, NK cells, decline DC migration, and promote CD4+ T cell differentiation into Th2 and Tregs (73).”
BackgroundThe mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.15 · Cited by 729
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.